| Debbie Rieza, | |
|
400 29th St Ste 105, Oakland, CA 94609-3546 | |
| (510) 268-8120 | |
| Not Available |
| Full Name | Debbie Rieza |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Intellectual & Developmental Disabilities |
| Location | 400 29th St Ste 105, Oakland, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013377621 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TM1800X | Psychologist - Intellectual & Developmental Disabilities | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Debbie Rieza, 400 29th St Ste 105, Oakland, CA 94609-3546 Ph: (510) 268-8120 | Debbie Rieza, 400 29th St Ste 105, Oakland, CA 94609-3546 Ph: (510) 268-8120 |
News Archive
Baxter International Inc. today announced the first approval of PREFLUCEL by the Austrian Agency for Health and Food Safety (AGES). The vaccine was shown to be effective in preventing seasonal influenza and is indicated for prophylaxis of influenza in adults and the elderly. PREFLUCEL is manufactured using Baxter's proprietary advanced Vero cell technology.
McKesson Corporation, the world's leading healthcare services company, today announced that it has signed a definitive agreement to sell its McKesson Asia Pacific business to Medibank Private Ltd., the largest private health services and insurer in Australia. The acquisition is expected to close in the second calendar quarter of 2010, subject to customary conditions, including regulatory review in Australia.
The study is the result of the collaboration between scientists at the Institut de Genetique Moleculaire de Montpellier, Universite Montpellier I & II, Montpellier, France, the Centre Hospitalier Universitaire Vaudois (CHUV) and at the Swiss Vaccine Research Institute, University of Lausanne, Lausanne, Switzerland.
Oncotarget recently published "Evaluation of cancer-derived myocardial impairments using a mouse model" which reported that Myocardial damage in cancer patients is emphasized as a cause of death; however, there are not many murine cachexia models to evaluate cancer-derived heart disorder.
The way that tetanus neurotoxin enters nerve cells has been discovered by UCL scientists, who showed that this process can be blocked, offering a potential therapeutic intervention for tetanus. This newly-discovered pathway could be exploited to deliver therapies to the nervous system, opening up a whole new way to treat neurological disorders such as motor neuron disease and peripheral neuropathies.
› Verified 3 days ago
Dr. Ronald C. Kimmons, PSYD, MSW, MA Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2303 25th Ave, Oakland, CA 94601 Phone: 510-219-6405 | |
Dr. Morgan E Bartholomew, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 970 Aileen St, Oakland, CA 94608 Phone: 661-992-6871 | |
Dr. Cheryl Jacques, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 5665 College Ave Ste 320c, Oakland, CA 94618 Phone: 510-653-0678 Fax: 510-898-9889 | |
Anna Wong, PSY Psychologist Medicare: Not Enrolled in Medicare Practice Location: 275 W Macarthur, Oakland, CA 94611 Phone: 510-752-1000 Fax: 510-752-1404 | |
Nadrienne A Pinnock, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3301 E 12th St, Oakland, CA 94601 Phone: 510-269-9030 | |
David C Roberts, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4283 Piedmont Ave, Suite B, Oakland, CA 94611 Phone: 510-655-1966 Fax: 510-595-4340 |